Lesopitron

Drug Profile

Lesopitron

Alternative Names: E 4424

Latest Information Update: 05 Dec 2006

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Esteve
  • Class Anxiolytics; Piperazines; Pyrimidines; Small molecules
  • Mechanism of Action Serotonin 1A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders; Peptic ulcer

Most Recent Events

  • 11 Oct 2000 A clinical study has been added to the Anxiety Disorders pharnacodynamics section
  • 21 Jun 2000 A study has been added to the Anxiety Disorders therapeutic trials section
  • 11 Nov 1997 Phase-II clinical trials for Anxiety disorders in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top